Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

RiVax, first ricin vaccine to enter human clinical trials

Dec. 2, 2004

Tetrodin studied in phase II trial of opiate-dependent subjects

Nov. 18, 2004

Lobeline enters clinical trials for methamphetamine addiction

Oct. 29, 2004

Nociceptin opioid receptor antagonist may be useful in the management of addictive disorders

Oct. 27, 2004

New mGluR5 antagonists prepared and tested at Addex

Oct. 26, 2004

Topiramate as a novel approach to alcoholism

Oct. 19, 2004

Promising clinical results reported for NicVAX in smoking cessation

Oct. 4, 2004

Full enrollment reached in phase II trial of CYT002-NicQb

Sep. 30, 2004

BPC-157 lessens effects of alcohol intoxication and withdrawal

Sep. 29, 2004

DOR BioPharma receives grant for ricin toxin vaccine work

Sep. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 28, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...